At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
NMC to continue its efforts to improve and enhance the quality of medical education in the country
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
Stable profits, low leverage to keep credit profiles comfortable
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The acquisition is based on an enterprise value of Rs. 1,660 crore
Subscribe To Our Newsletter & Stay Updated
